300171 东富龙
已收盘 10-31 15:00:00
资讯
新帖
简况
股市必读:东富龙(300171)10月30日董秘有最新回复
证券之星 · 10-30 19:49
股市必读:东富龙(300171)10月30日董秘有最新回复
东富龙:制药装备行业竞争激烈
证券之星 · 10-30 07:36
东富龙:制药装备行业竞争激烈
股市必读:东富龙三季报 - 第三季度单季净利润同比增长120.91%
证券之星 · 10-28
股市必读:东富龙三季报 - 第三季度单季净利润同比增长120.91%
东富龙(300171.SZ)发布前三季度业绩,归母净利润1.32亿元,下降13.86%
智通财经 · 10-28
东富龙(300171.SZ)发布前三季度业绩,归母净利润1.32亿元,下降13.86%
10月27日东富龙发生1笔大宗交易 成交金额240.63万元
证券之星 · 10-27
10月27日东富龙发生1笔大宗交易 成交金额240.63万元
股市必读:东富龙(300171)10月24日董秘有最新回复
证券之星 · 10-26
股市必读:东富龙(300171)10月24日董秘有最新回复
东富龙:主张从“价格竞争”转向“价值竞争”
证券之星 · 10-24
东富龙:主张从“价格竞争”转向“价值竞争”
东富龙:AI技术应用于设备维护与智能控制
证券之星 · 10-21
东富龙:AI技术应用于设备维护与智能控制
东富龙:布局国际市场提升品牌知名度
证券之星 · 10-20
东富龙:布局国际市场提升品牌知名度
股市必读:东富龙(300171)10月10日董秘有最新回复
证券之星 · 10-12
股市必读:东富龙(300171)10月10日董秘有最新回复
东富龙:伯豪生物为参股子公司未纳入合并报表
证券之星 · 10-10
东富龙:伯豪生物为参股子公司未纳入合并报表
东富龙:降息或刺激药企设备采购需求
证券之星 · 10-10
东富龙:降息或刺激药企设备采购需求
股市必读:东富龙(300171)9月30日董秘有最新回复
证券之星 · 10-08
股市必读:东富龙(300171)9月30日董秘有最新回复
股市必读:东富龙(300171)9月24日董秘有最新回复
证券之星 · 09-24
股市必读:东富龙(300171)9月24日董秘有最新回复
东富龙:持股烟台博赛生物科技20%
证券之星 · 09-22
东富龙:持股烟台博赛生物科技20%
股市必读:东富龙(300171)9月19日披露最新机构调研信息
证券之星 · 09-21
股市必读:东富龙(300171)9月19日披露最新机构调研信息
东富龙新注册《基于无菌机械手的灌装机控制系统V1.0》项目的软件著作权
证券之星 · 09-18
东富龙新注册《基于无菌机械手的灌装机控制系统V1.0》项目的软件著作权
东富龙:如有并购重组计划将及时披露
证券之星 · 09-18
东富龙:如有并购重组计划将及时披露
东富龙(300171)披露2025年中期权益分派实施公告,9月17日股价下跌1.03%
证券之星 · 09-17
东富龙(300171)披露2025年中期权益分派实施公告,9月17日股价下跌1.03%
东富龙(300171)披露2025年半年度跟踪报告,9月16日股价上涨2.17%
证券之星 · 09-16
东富龙(300171)披露2025年半年度跟踪报告,9月16日股价上涨2.17%
加载更多
公司概况
公司名称:
东富龙科技集团股份有限公司
所属行业:
专用设备制造业
上市日期:
2011-02-01
主营业务:
东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是液态食品前处理线,食品冻干系统,液体灌装线及无菌灌装线等包装设备。
发行价格:
86.00
{"stockData":{"symbol":"300171","market":"SZ","secType":"STK","nameCN":"东富龙","latestPrice":16.96,"timestamp":1761894225000,"preClose":16.84,"halted":0,"volume":21953728,"delay":0,"changeRate":0.0071,"floatShares":563000000,"shares":766000000,"eps":0.2258,"marketStatus":"已收盘","change":0.12,"latestTime":"10-31 15:00:00","open":16.82,"high":17.2,"low":16.7,"amount":372000000,"amplitude":0.0297,"askPrice":16.99,"askSize":74,"bidPrice":16.96,"bidSize":52,"shortable":0,"etf":0,"ttmEps":0.2258,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.84,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":18.52,"lowLimit":15.16,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":765828040,"isCdr":false,"pbRate":1.64,"roa":"--","peRate":75.110717,"roe":"1.68%","epsLYR":0.26,"committee":0.301711,"marketValue":12988000000,"turnoverRate":0.039,"status":0,"floatMarketCap":9543000000},"requestUrl":"/m/hq/s/300171","defaultTab":"news","newsList":[{"id":"2579171862","title":"股市必读:东富龙(300171)10月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579171862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579171862?lang=zh_cn&edition=full","pubTime":"2025-10-31 03:49","pubTimestamp":1761853773,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘,东富龙报收于16.84元,下跌1.81%,换手率5.0%,成交量28.14万手,成交额4.76亿元。公司将根据行业及市场环境的变化情况,合理推进募投项目的建设与投产工作。当日关注点来自交易信息汇总:10月30日主力资金净流出2508.76万元,散户资金净流入4195.99万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100006061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2579419601","title":"东富龙:制药装备行业竞争激烈","url":"https://stock-news.laohu8.com/highlight/detail?id=2579419601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579419601?lang=zh_cn&edition=full","pubTime":"2025-10-30 15:36","pubTimestamp":1761809775,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙10月30日在投资者关系平台上答复投资者关心的问题。当前,国内外制药装备行业竞争依然激烈,公司坚持通过自主创新和战略实施提升自身市场竞争力,为客户提供满意的产品及整体解决方案,赢得客户的信任从而获取更多的优质订单。公司将根据行业及市场环境的变化情况,合理推进募投项目的建设与投产工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000024493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK1191","BK1574","01477","BK0251"],"gpt_icon":0},{"id":"2579995294","title":"股市必读:东富龙三季报 - 第三季度单季净利润同比增长120.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579995294","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579995294?lang=zh_cn&edition=full","pubTime":"2025-10-29 03:18","pubTimestamp":1761679123,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2025年9月30日,东富龙股东户数环比下降2.14%,户均持股数量上升至2.44万股。股本股东变化股东户数变动截至2025年9月30日,东富龙股东户数为3.14万户,较6月30日减少688.0户,减幅为2.14%;户均持股数量由上期的2.39万股增至2.44万股,户均持股市值为34.74万元。业绩披露要点财务报告东富龙2025年三季报显示,公司主营收入37.04亿元,同比上升6.14%;归母净利润1.32亿元,同比下降13.86%;扣非净利润1.05亿元,同比下降20.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900003491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171"],"gpt_icon":0},{"id":"2578935942","title":"东富龙(300171.SZ)发布前三季度业绩,归母净利润1.32亿元,下降13.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578935942","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578935942?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:12","pubTimestamp":1761642770,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东富龙(300171.SZ)发布2025年三季度报告,该公司前三季度营业收入为37.04亿元,同比增长6.14%。归属于上市公司股东的净利润为1.32亿元,同比减少13.86%。归属于上市公司股东的扣除非经常性损益的净利润为1.05亿元,同比减少20.15%。基本每股收益为0.1729元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300171"],"gpt_icon":0},{"id":"2578582615","title":"10月27日东富龙发生1笔大宗交易 成交金额240.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578582615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578582615?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:53","pubTimestamp":1761555203,"startTime":"0","endTime":"0","summary":"证券之星消息,10月27日东富龙发生大宗交易,交易数据如下:大宗交易成交价格15.23元,相对当日收盘价溢价2.49%,成交15.8万股,成交金额240.63万元,买方营业部为光大证券股份有限公司宁波柳汀街证券营业部,卖方营业部为光大证券股份有限公司宁波柳汀街证券营业部。近三个月该股共发生1笔大宗交易,合计成交1580.0手,溢价成交1笔。截至2025年10月27日收盘,东富龙报收于14.86元,下跌0.27%,换手率1.72%,成交量9.65万手,成交额1.44亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2578654034","title":"股市必读:东富龙(300171)10月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578654034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578654034?lang=zh_cn&edition=full","pubTime":"2025-10-27 03:39","pubTimestamp":1761507551,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,东富龙报收于14.9元,上涨0.61%,换手率1.17%,成交量6.6万手,成交额9806.1万元。当日关注点来自交易信息汇总:10月24日主力资金净流出920.64万元,散户资金净流入817.18万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700000944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2577951560","title":"东富龙:主张从“价格竞争”转向“价值竞争”","url":"https://stock-news.laohu8.com/highlight/detail?id=2577951560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577951560?lang=zh_cn&edition=full","pubTime":"2025-10-24 15:33","pubTimestamp":1761291192,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙(300171)10月24日在投资者关系平台上答复投资者关心的问题。投资者提问:公司有没想过和同行业公司弄一个价格攻守同盟,免得行业恶性竞争内卷,弄的公司没利润了东富龙回复:您好,公司及时跟踪市场环境的变动,主张从“价格竞争”转向“价值竞争”。公司将坚持产品创新,提升产品的核心竞争力,打造差异化竞争优势,以更优质的产品服务好客户,取得优质订单。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400022482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2577587386","title":"东富龙:AI技术应用于设备维护与智能控制","url":"https://stock-news.laohu8.com/highlight/detail?id=2577587386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577587386?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:48","pubTimestamp":1761050889,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙10月20日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100034493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2576383143","title":"东富龙:布局国际市场提升品牌知名度","url":"https://stock-news.laohu8.com/highlight/detail?id=2576383143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576383143?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:48","pubTimestamp":1760950091,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙10月20日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000020339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2575128504","title":"股市必读:东富龙(300171)10月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2575128504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575128504?lang=zh_cn&edition=full","pubTime":"2025-10-13 03:13","pubTimestamp":1760296391,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,东富龙报收于14.74元,上涨0.89%,换手率2.08%,成交量11.7万手,成交额1.73亿元。董秘最新回复投资者: 公司帐上还有多少现金?董秘: 您好,截至2025年6月30日,公司的现金及现金等价物账面金额为28.44亿元。有传2025.9.19伯豪生物拟申请上市,是真的吗?当日关注点来自交易信息汇总:10月10日主力资金净流入997.26万元,显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2574126103","title":"东富龙:伯豪生物为参股子公司未纳入合并报表","url":"https://stock-news.laohu8.com/highlight/detail?id=2574126103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574126103?lang=zh_cn&edition=full","pubTime":"2025-10-10 16:54","pubTimestamp":1760086451,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙10月10日在投资者关系平台上答复投资者关心的问题。请问,公司是伯豪生物的第一大股东而非控股股东,是作为少数股东处理吗?伯豪生物未纳入合并报表?若纳入,有没有具体经营数据?有传2025.9.19伯豪生物拟申请上市,是真的吗?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000025506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2574126385","title":"东富龙:降息或刺激药企设备采购需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2574126385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574126385?lang=zh_cn&edition=full","pubTime":"2025-10-10 16:45","pubTimestamp":1760085927,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙10月10日在投资者关系平台上答复投资者关心的问题。降息有利于降低部分药企的资金成本,刺激其设备采购需求。但由于各国降息周期不同,各药企资金实力、研发投入、在研管线数量及产能建设规模等不同,降息对制药装备行业需求的影响存在不确定性因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000025306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2574977242","title":"股市必读:东富龙(300171)9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2574977242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574977242?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:36","pubTimestamp":1759955773,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘,东富龙报收于14.25元,上涨1.35%,换手率1.05%,成交量5.91万手,成交额8396.96万元。董秘最新回复投资者: 董秘一直以来都能及时,诚恳的与我们投资者互动,对此我表示衷心的感谢!我对东富龙是抱着很大的期望与坚定的意志的!希望转告郑总,多维布局医药生物,医疗器械,养老产业,协同发展!让东富龙早日成为世界的东富龙!当日关注点来自交易信息汇总:9月30日主力资金净流出207.37万元,占总成交额2.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900001298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0},{"id":"2570053089","title":"股市必读:东富龙(300171)9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570053089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570053089?lang=zh_cn&edition=full","pubTime":"2025-09-25 00:59","pubTimestamp":1758733151,"startTime":"0","endTime":"0","summary":"截至2025年9月24日收盘,东富龙报收于14.18元,上涨2.24%,换手率1.17%,成交量6.56万手,成交额9206.72万元。董秘最新回复投资者: 林园说未来二十年中国有几亿的老人,他一直看好医药与养老。建议公司做好主业的同时,大力发展养老产业或在养老产业进行投资控股,只有这样公司才能做大做强啊!当日关注点来自交易信息汇总:9月24日主力资金净流入619.49万元,显示主力对个股短期态度偏积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2569048512","title":"东富龙:持股烟台博赛生物科技20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569048512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569048512?lang=zh_cn&edition=full","pubTime":"2025-09-22 15:46","pubTimestamp":1758527184,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙(300171)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:能否介绍一下烟台博赛生物科技有限公司的成立?公司持股多少?是公司转型生物医药的开篇吗?东富龙回复:您好,公司在烟台赛博生物科技有限公司的股权占比为 20%,属于参股性投资,不参与实际经营。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200016493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171","159837"],"gpt_icon":0},{"id":"2569216227","title":"股市必读:东富龙(300171)9月19日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2569216227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569216227?lang=zh_cn&edition=full","pubTime":"2025-09-22 02:27","pubTimestamp":1758479233,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,东富龙报收于14.17元,下跌2.68%,换手率2.04%,成交量11.46万手,成交额1.64亿元。当日关注点来自交易信息汇总:9月19日主力资金净流出1054.22万元,游资资金净流入1104.43万元。来自机构调研要点:公司回应股价低迷问题,表示将通过提升核心竞争力和加强海外营销网络建设增强投资者信心。来自机构调研要点:公司正在推进智能制造整体解决方案,可为客户提供MES、WMS、QMS等信息化系统软件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200000806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2568402760","title":"东富龙新注册《基于无菌机械手的灌装机控制系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2568402760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568402760?lang=zh_cn&edition=full","pubTime":"2025-09-19 01:47","pubTimestamp":1758217635,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东富龙新注册了《基于无菌机械手的灌装机控制系统V1.0》项目的软件著作权。今年以来东富龙新注册软件著作权3个,较去年同期增加了50%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了1.58亿元,同比增2.95%。通过天眼查大数据分析,东富龙科技集团股份有限公司共对外投资了24家企业,参与招投标项目740次;财产线索方面有商标信息69条,专利信息1680条,著作权信息68条;此外企业还拥有行政许可141个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900001166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2568547710","title":"东富龙:如有并购重组计划将及时披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2568547710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568547710?lang=zh_cn&edition=full","pubTime":"2025-09-18 20:48","pubTimestamp":1758199699,"startTime":"0","endTime":"0","summary":"证券之星消息,东富龙(300171)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价几年来一直低迷,有没有重组收购的计划东富龙回复:您好,公司深耕生物医药行业三十余载,致力于为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司如有并购重组计划,将根据相关法律法规及信息披露要求及时履行信息披露义务。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800035265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161123","300171","BK0251"],"gpt_icon":0},{"id":"2568977684","title":"东富龙(300171)披露2025年中期权益分派实施公告,9月17日股价下跌1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568977684","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568977684?lang=zh_cn&edition=full","pubTime":"2025-09-17 23:00","pubTimestamp":1758121248,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘,东富龙报收于14.42元,较前一交易日下跌1.03%,最新总市值为110.43亿元。该股当日开盘14.56元,最高14.56元,最低14.36元,成交额达8390.4万元,换手率为1.03%。公司近日发布公告,披露2025年中期权益分派实施方案。本次权益分派股权登记日为2025年9月24日,除权除息日为2025年9月25日。本次分配方案与股东大会审议通过的方案一致,期间股本及回购股份数量未发生变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"gpt_icon":0},{"id":"2567486950","title":"东富龙(300171)披露2025年半年度跟踪报告,9月16日股价上涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567486950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567486950?lang=zh_cn&edition=full","pubTime":"2025-09-16 22:33","pubTimestamp":1758033199,"startTime":"0","endTime":"0","summary":"截至2025年9月16日收盘,东富龙报收于14.57元,较前一交易日上涨2.17%,最新总市值为111.58亿元。近日,中信证券股份有限公司发布了关于东富龙科技集团股份有限公司2025年半年度跟踪报告。公告显示,中信证券对东富龙2025年上半年的保荐工作进行了持续跟踪。报告期内开展现场检查1次,未发现重大问题。报告期内,中信证券因担任其他项目保荐人被深交所出具监管函,目前已完成整改并追责。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600038293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761973472156,"stockEarnings":[{"period":"1week","weight":0.1383},{"period":"1month","weight":0.1902},{"period":"3month","weight":0.0993},{"period":"6month","weight":0.4557},{"period":"1year","weight":0.3363},{"period":"ytd","weight":0.288}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.1109},{"period":"6month","weight":0.2061},{"period":"1year","weight":0.2058},{"period":"ytd","weight":0.1799}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东富龙科技集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"31415人(较上一季度减少2.14%)","perCapita":"17910股","listingDate":"2011-02-01","address":"上海市闵行区都会路1509号4幢","registeredCapital":"76582万元","survey":" 东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是液态食品前处理线,食品冻干系统,液体灌装线及无菌灌装线等包装设备。","listedPrice":86},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东富龙,300171,东富龙股票,东富龙股票老虎,东富龙股票老虎国际,东富龙行情,东富龙股票行情,东富龙股价,东富龙股市,东富龙股票价格,东富龙股票交易,东富龙股票购买,东富龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}